Aimfinity Investment Corp. I Files 8-K on Obligations and Equity Sales

TL;DR

AIMWF filed an 8-K detailing new debt obligations and unregistered equity sales. Watch for details.

AI Summary

Aimfinity Investment Corp. I filed an 8-K on September 29, 2025, disclosing the creation of direct financial obligations and unregistered sales of equity securities. The filing also includes Regulation FD disclosures and financial statements. Specific details regarding the nature and terms of these obligations and sales are provided within the document.

Why It Matters

This filing indicates potential new financial commitments or equity issuances by Aimfinity Investment Corp. I, which could impact its financial structure and shareholder value.

Risk Assessment

Risk Level: medium — The filing involves financial obligations and unregistered equity sales, which can introduce financial risk and dilution concerns.

Key Numbers

• 20250928 — Report Date (The period the 8-K filing pertains to.)
• 20250929 — Filing Date (The date the 8-K was officially submitted to the SEC.)

Key Players & Entities

• Aimfinity Investment Corp. I (company) — Filer of the 8-K report
• 0001903464 (company) — Central Index Key for Aimfinity Investment Corp. I
• AIMWF (company) — Ticker symbol for Aimfinity Investment Corp. I
• 11.50 (dollar_amount) — Exercise price for warrants

FAQ

Key Financial Figures

• $11.50 — ordinary share at an exercise price of $11.50 AIMUF OTC Market Group, Inc. New
• $0.05 — the "Trust Account") an amount equal to $0.05 for each public share for each one-mont
• $55,823.8 — issued an unsecured promissory note of $55,823.8 (the "Extension Note") to I-Fa Chang, a
• $10.00 — rdinary shares at a conversion price of $10.00 per share. The Extension Note was issue

Filing Documents

• ea0259164-8k425_aimfinity1.htm (8-K) — 49KB
• ea025916401ex10-1_aimfinity1.htm (EX-10.1) — 31KB
• ea025916401ex99-1_aimfinity1.htm (EX-99.1) — 14KB
• 0001213900-25-093061.txt ( ) — 331KB
• aimwf-20250928.xsd (EX-101.SCH) — 4KB
• aimwf-20250928_def.xml (EX-101.DEF) — 27KB
• aimwf-20250928_lab.xml (EX-101.LAB) — 38KB
• aimwf-20250928_pre.xml (EX-101.PRE) — 26KB
• ea0259164-8k425_aimfinity1_htm.xml (XML) — 7KB

03 Creation of a Direct Financial Obligation or an Obligation

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant As previously disclosed by Aimfinity Investment Corp. I ("AIMA" or the "Company") in its Current Report on Form 8-K filed on October 16, 2023, on October 13, 2023, the Company entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), with Docter Inc., a Delaware corporation ("Docter"), Aimfinity Investment Merger Sub I, a Cayman Islands exempted company and wholly-owned subsidiary of AIMA ("Purchaser"), and Aimfinity Investment Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser ("Merger Sub"), pursuant to which AIMA will complete a business combination (the "Business Combination") with Docter that involves a reincorporation merger and an acquisition merger. The Purchaser shall survive the Business Combination and be referred to as "PubCo" after the Business Combination. On January 9, 2025, the Company held an extraordinary general meeting, where the shareholders of the Company approved to amend the Company's amended and restated memorandum and articles of associations (the "Charter") to allow the Company until January 28, 2025 to consummate an initial business combination and may elect to extend the period to consummate an initial business combination up to nine times, each by an additional one-month period (each, a "Monthly Extension"), for a total of up to nine months to October 28, 2025, by depositing into the Company's trust account (the "Trust Account") an amount equal to $0.05 for each public share for each one-month extension. On September 28, 2025, the Company issued an unsecured promissory note of $55,823.8 (the "Extension Note") to I-Fa Chang, a member and manager of Aimfinity Investment LLC, the sponsor of the Company (the "Sponsor"), as the Sponsor's designee, to evidence the payments made for $55,823

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. The disclosures set forth above in Items 1.01 and 2.03 of this Current Report on Form 8-K are incorporated by reference herein. 1

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 29, 2025, the Company issued a press release (the "Press Release") announcing the New Extension. A copy of the Press Release is furnished as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. IMPORTANT NOTICES As disclosed previously on the Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023, on October 13, 2023, AIMA entered into that certain Merger Agreement, with Docter, Purchaser, and Merger Sub, pursuant to which AIMA will complete a business combination with Docter that involves a reincorporation merger and an acquisition merger. This Current Report on Form 8-K contains certain "forward-looking about the proposed transactions described above, and the parties' perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transactions, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the proposed transactions. The words "expect," "believe," "estimate," "intend," "plan" and similar expressions indicate forward-looking

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Promissory Note, dated September 28, 2025, issued by the Company to I-Fa Chang. 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aimfinity Investment Corp. I Date: September 29, 2025 By: /s/ I-Fa Chang Name: I-Fa Chang Title: Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR